Clopidogrel and aspirin both inhibit platelet aggregation, but have differing mechanisms of action that are additive in terms of antithrombotic function. The additive antithrombotic effect of aspirin and clopidogrel combination therapy provides additional clinical benefit compared to monotherapy in some circumstances, but the risk of major bleeding with combination therapy is greater than with either agent alone.(1-3)
Antiplatelet agents (APA) are used to reduce the risk of major cardiovascular events in various sett...
10.1111/j.1538-7836.2006.01926.xJournal of Thrombosis and Haemostasis471638-1639JTHO
The introduction of aspirin as an anti-thrombotic agent some 50 years ago has changed the therapeuti...
The possible additive antiplatelet effects of aspirin and clopidogrel have been explored in the Clop...
AbstractObjective: Many thromboembolic events occur in patients taking aspirin. Dual therapy with as...
AbstractOBJECTIVESWe sought to compare the inhibitory effects of the combination of two doses of asp...
Mario Bollat,i Fiorenzo Gaita, Matteo AnselminoDepartment of Internal Medicine, Division of Cardiolo...
The use of multiple medications (ie,polypharmacy) has no standard defi-nition in the medical literat...
- Platelet aggregation inhibitors reduce the risk of complications during and after acute coronary s...
Platelet aggregation plays a key role in the development of complications of atherosclerosis. By inh...
Aspirin and clopidogrel monotherapies are effective treatments for preventing vascular disease. Howe...
Antiplatelet therapy is the cornerstone for both primary and secondary prevention therapies for isch...
Platelet activation plays a critical role both in spontaneous coronary artery thrombosis due to athe...
Abstract: Platelets play a pivotal role in the pathogenesis of atherothrombosis, believed to be inte...
Aspirin (acetylsalicylic acid) is the most widely studied and prescribed antiplatelet drug for patie...
Antiplatelet agents (APA) are used to reduce the risk of major cardiovascular events in various sett...
10.1111/j.1538-7836.2006.01926.xJournal of Thrombosis and Haemostasis471638-1639JTHO
The introduction of aspirin as an anti-thrombotic agent some 50 years ago has changed the therapeuti...
The possible additive antiplatelet effects of aspirin and clopidogrel have been explored in the Clop...
AbstractObjective: Many thromboembolic events occur in patients taking aspirin. Dual therapy with as...
AbstractOBJECTIVESWe sought to compare the inhibitory effects of the combination of two doses of asp...
Mario Bollat,i Fiorenzo Gaita, Matteo AnselminoDepartment of Internal Medicine, Division of Cardiolo...
The use of multiple medications (ie,polypharmacy) has no standard defi-nition in the medical literat...
- Platelet aggregation inhibitors reduce the risk of complications during and after acute coronary s...
Platelet aggregation plays a key role in the development of complications of atherosclerosis. By inh...
Aspirin and clopidogrel monotherapies are effective treatments for preventing vascular disease. Howe...
Antiplatelet therapy is the cornerstone for both primary and secondary prevention therapies for isch...
Platelet activation plays a critical role both in spontaneous coronary artery thrombosis due to athe...
Abstract: Platelets play a pivotal role in the pathogenesis of atherothrombosis, believed to be inte...
Aspirin (acetylsalicylic acid) is the most widely studied and prescribed antiplatelet drug for patie...
Antiplatelet agents (APA) are used to reduce the risk of major cardiovascular events in various sett...
10.1111/j.1538-7836.2006.01926.xJournal of Thrombosis and Haemostasis471638-1639JTHO
The introduction of aspirin as an anti-thrombotic agent some 50 years ago has changed the therapeuti...